stockrowDanaher Corporation
DHR Healthcare Diagnostics & Research
Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024.
- Revenue
- +8.28%
- EPS
- +36.7%
- Free cash flow
- +19.1%
- Total debt
- +44.9%
Quarter to September 2026, against a year earlier
Follow DHR
Alert me
Danaher Corporation (DHR) Gross margin
Danaher Corporation's gross margin over the twelve months to 30 September 2026 was 58.6%, down 0.5 percentage points from fiscal 2025 (59.1%). Over the past ten years it has ranged from 53.8% (fiscal 2015) to 61.4% (fiscal 2021); the current reading is higher than 73% of that period. That is above the Diagnostics & Research industry median of 48.3% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 59.1% | (0.39) |
| FY2024 | 59.5% | 0.76 |
| FY2023 | 58.7% | (2.02) |
| FY2022 | 60.8% | (0.68) |
| FY2021 | 61.4% | 5.46 |
| FY2020 | 56.0% | 0.24 |
| FY2019 | 55.7% | (0.01) |
| FY2018 | 55.8% | 0.52 |
| FY2017 | 55.2% | (0.06) |
| FY2016 | 55.3% | 1.45 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 58.5% | 0.90 |
| Jun 2026 | 57.6% | (2.70) |
| Mar 2026 | 60.3% | 2.34 |
| Dec 2025 | 58.0% | (0.20) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ILMN Illumina, Inc. compare | 67.9% |
| IDXX IDEXX Laboratories, Inc. compare | 62.7% |
| MTD Mettler-Toledo International, Inc. compare | 60.3% |
| DHR Danaher Corporation | 58.6% |
| A Agilent Technologies, Inc. compare | 53.8% |
| WAT Waters Corporation compare | 49.5% |
| TMO Thermo Fisher Scientific Inc. compare | 41.1% |
| IQV IQVIA Holdings Inc. compare | 33.1% |
| NTRA Natera, Inc. compare | 0.00% |
| Diagnostics & Research industry median | 48.3% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on DHR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement